BlackRock’s Sanara MedTech SMTI Stock Holding History
Bought
Maintained
Sold
Other funds holding SMTI
VCM
SWM
BlackRock's SMTI Position: Q1 2026 in Review
BlackRock increased its Sanara MedTech (SMTI) stake by 7% in Q1 2026, buying an estimated $306K and bringing the position to 228,767 shares worth $3.93M. The position accounts for ﹤0.01% of the portfolio, ranked #3926.
BlackRock first reported a position in SMTI in Q2 2021 and has held it in 20 quarters since. The position peaked at $8.42M in Q4 2023. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.
- BlackRock held 228,767 shares of Sanara MedTech worth $3.93M as of Q1 2026.
- BlackRock bought 14,893 Sanara MedTech shares in Q1 2026, an estimated $306K.
- Sanara MedTech made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3926 holding.
- BlackRock first reported a position in Sanara MedTech in Q2 2021 and has held it in 20 quarters since.
- BlackRock's Sanara MedTech position peaked at $8.42M in Q4 2023.
- 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.